Federal Register / Vol. 72, No. 80 / Thursday, April 26, 2007 / Notices 20851 

Dated: April 20, 2007. 

Joan F. Karr, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. E7–7977 Filed 4–25–07; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES (HHS) 

Centers for Disease Control and 

Prevention 

National Institute for Occupational 

Safety and Health (NIOSH); Advisory 

Board on Radiation and Worker Health 

(ABRWH) 

Correction: This notice was published 

in the Federal Register on April 17, 

2007, Volume 72, Number 73, pages 

19207–19208. In addition to the 

ABRWH meeting scheduled for May 2–

4, 2007, a meeting of the Subcommittee 

for Dose Reconstruction Reviews 

(SDRR) will also be convened on May 2, 

2007. The meeting times for the 

ABRWH have been changed. The 

matters to be discussed by the SDRR are 

included below. 

Subcommittee Meeting Time and Date 

9 a.m.–11:30 a.m., May 2, 2007. 

Committee Meeting Times and Dates 

12:30 p.m.–4:30 p.m., May 2, 2007. 

8 a.m.–5:45 p.m., May 3, 2007. 

8 a.m.–2:30 p.m., May 4, 2007. 

Matters to be Discussed: The topics 

for the Subcommittee meeting include 

Discussion of Reviewed Cases; Selection 

of Cases to Be Reviewed; and Discussion 

of Overall Review Process. 

FOR FURTHER INFORMATION CONTACT: Dr. 

Lewis V. Wade, Executive Secretary, 

NIOSH, CDC, 4676 Columbia Parkway, 

Cincinnati, Ohio 45226, telephone 

513.533.6825, fax 513.533.6826. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both CDC 

and the Agency for Toxic Substances 

and Disease Registry. 

Dated: April 20, 2007. 

Elaine L. Baker, 

Acting Director, Management Analysis and 

Services Office Centers for Disease Control 

and Prevention. 

[FR Doc. E7–8077 Filed 4–25–07; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Submission for OMB Review; 

Comment Request 

Title: OOR Quarterly Performance 

Report, Form ORR–6. 

OMB No.: 0970–0036. 

Description: As required by section 

412(e) of the Immigration and 

Nationality Act, the Administration for 

Children and Families (ACF), Office of 

Refugee Resettlement (ORR), is 

requesting the information from Form 

ORR–6 to determine the effectiveness of 

the State cash and medical assistance, 

social services, and targeted assistance 

programs. State-by-State Refugee Cash 

Assistance (RCA) and Refugee Medical 

Assistance (RMA) utilization rates 

derived from Form ORR–6 are 

calculated for use in formulating 

program initiatives, priorities, 

standards, budget requests, and 

assistance policies. ORR regulations 

require that State Refugee Resettlement 

and Wilson-Fish agencies, and local and 

Tribal governments complete Form 

ORR–6 in order to participate in the 

above-mentioned programs. 

Respondents: State Refugee 

Resettlement and Wilson-Fish Agencies, 

local, and Tribal governments. 

ANNUAL BURDEN ESTIMATES

Instrument Number of 

respondents 

Number of 

responses 

per 

respondent 

Average 

burden hours 

per response 

Total burden 

hours 

ORR–6 ............................................................................................................. 50 4 3.875 775 

Estimated Total Annual Burden 

Hours: 775. 

Additional Information: Copies of the 

proposed collection may be obtained by 

writing to the Administration for 

Children and Families, Office of 

Administration, Office of Information 

Services, 370 L’Enfant Promenade, SW., 

Washington, DC 20447, Attn: ACF 

Reports Clearance Officer. All requests 

should be identified by the title of the 

information collection. E-mail address: 

infocollection@acf.hhs.gov. OMB Comment: OMB is required to 

make a decision concerning the 

collection of information between 30 

and 60 days after publication of this 

document in the Federal Register. 

Therefore, a comment is best assured of 

having its full effect if OMB receives it 

within 30 days of publication. Written 

comments and recommendations for the 

proposed information collection should 

be sent directly to the following: Office 

of Management and Budget, Paperwork 

Reduction Project, Fax: 202–395–6974, 

Attn: Desk Officer for the 

Administration for Children and 

Families. 

Dated: April 23, 2007. 

Robert Sargis, 

Reports Clearance Officer. 

[FR Doc. 07–2062 Filed 4–25–07; 8:45 am] 

BILLING CODE 4184–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Indian Health Service 

Maternal and Child Health Program 

Announcement Type: New Limited 

Competition. 

Funding Announcement Number: 

HHS–2007–IHS–MHCEP–0001. 

Catalog of Federal Domestic 

Assistance Numbers: 93.231. 

DATES: Key Dates: 

Application Deadline Date: May 15, 

2007. 

Review Date: May 17, 2007. 

Earliest Anticipated Start Date: May 

30, 2007. 

Funding Opportunity Description 

The Indian Health Service (IHS) 

Maternal and Child Health Program 

(MCH) announces a limited competition 

for cooperative agreements for 

applications responding to the 

Secretaries’ Initiative on Closing the 

Health Disparities Gap for Sudden 

Infant Death Syndrome (SIDS) and 

Infant Mortality (IM). This program is 

authorized under Snyder Act, 25 U.S.C. 

13, 25 U.S.C. 1621(m), 25 U.S.C. 


rwilkins on PROD1PC63 with NOTICES
20852 Federal Register / Vol. 72, No. 80 / Thursday, April 26, 2007 / Notices 

1653(c), and Indian Health Care 

Improvement Act Public Law 94–437, as 

amended by Public Law 102–573. This 

program is described at 93.231 in the 

Catalog of Federal Domestic Assistance 

(CFDA). 

This limited competition seeks to 

improve American Indian and Alaska 

Native (AI/AN) maternal and infant 

outcomes in key populations through 

surveillance and outreach projects 

conducted by existing Tribal and urban 

Indian epidemiology centers. 

Enhancement of MCH epidemiology 

activities currently underway in select 

disparate populations is necessary to 

reduce IM. 

The purpose of this announcement is 

to respond to the Department of Health 

and Human Services Closing the Health 

Disparities Gap on SIDS and IM in AI/ 

AN populations. Urban and Tribal 

Epidemiology Centers provide 

surveillance, monitoring, conduct 

studies and apply interventions to 

reduce risk of IM in defined regions. 

Enhancement of AI/AN MCH 

surveillance will build Tribal public 

health infrastructure and complement 

outreach projects. Existing expertise in 

MCH epidemiology and a history of 

regional MCH support is required to 

address risk factors of SIDS and IM. 

This limited competition will augment 

existing expertise in MCH epidemiology 

to address risk factors of SIDS and IM. 

This announcement is specifically 

geared toward all eligible MCH 

programs who lack resources to serve 

targeted AI/AN populations under this 

initiative. Eligible Epi Centers under 

this announcement are geographically 

located in Arizona, Iowa, Nebraska, 

Nevada, North Dakota, South Dakota, 

Utah, and/or with urban Indian 

organizations. The nature of these 

projects will require collaboration with 

the IHS MCH Program to: (1) Coordinate 

activities, (2) participate in projects, 

investigations, or studies of national 

scope, and (3) share surveillance and 

other data collected, in compliance with 

the Federal Privacy Act, HIPAA, or 

similar Tribal laws. The IHS will, 

therefore, have substantial 

programmatic involvement in these 

projects (see II. B. IHS Activities below). 

II. Award Information 

Type of Awards: Cooperative 

Agreement. 

Estimated Funds Available: The total 

amount identified for fiscal year (FY) 

2007 is $375,000. The awards are for 

twelve months in duration and the 

average award is approximately 

$125,000. Awards under this 

announcement are subject to the 

availability of funds. 

Anticipated Number of Awards: An 

estimate of three awards will be made 

under this program announcement. 

Project Period: Twelve months. 

Award Amount: $125,000, per year. 

A. Requirements of Recipient Activities 

Submit a proposal including all of the 

following: 

1. Maintain a MCH Program Manager 

to support MCH activities within the 

Urban Indian or Tribal Epidemiology 

Center (TEC) or regional TEC. 

2. Enhance an existing workplan to 

conduct MCH Regional Surveillance 

that complements state and national 

activities. Assist AI/AN communities, 

Tribal organizations, and urban Indian 

organizations in MCH surveillance 

systems and identifying their highest 

priority MCH health status objectives 

based on epidemiologic data. 

3. Elaborate on Perinatal data systems 

to be used and integrate into current epi 

activities i.e. Sexually Transmitted 

Diseases’, injuries, tobacco, issues 

affecting women during the child 

bearing years, infants and children. 

Include clinical data, vital statistics, 

epidemiologic data, and monitoring of 

local Tribal or community SIDS 

initiatives. States with the Centers for 

Disease Control/Prevention (CDC) 

Pregnancy Risk Assessment Monitoring 

Surveillance system provide an ongoing 

and ready source of data on maternal 

health and birth outcomes. 

4. Annotate how staff will maintain 

knowledge of the scientific literature 

related to MCH epidemiology, statistics, 

surveillance, Healthy People 2010 

Objectives, and other disease control 

activities. 

5. Monitor 2010 goals, MCH Chapter 

16 objectives and sub-objectives for AI/ 

AN populations. 

6. Assist Tribal clinics, urban and 

direct care perinatal programs in their 

evidence-based interventions around 

SIDS Risk Reduction and ‘‘Closing the 

Health Gap in Infant Mortality,’’ where 

applicable (i.e., Aberdeen, Billings and 

Navajo Areas). 

7. Participate in the sharing, 

improving, and disseminating aggregate 

perinatal and MCH health data at local, 

regional, national meetings and with 

other IHS Programs for purposes of 

advocacy for AI/AN communities. 

8. Develop and implement MCH 

epidemiologic studies that have 

practical application in improving the 

health status of constituent 

communities. Studies may require 

Institutional Review Board approval if 

human subjects are involved. 

9. Develop and implement MCH 

Epidemiology and prevention programs 

in cooperation with other public health 

entities. 

10. Ensure the coordination of 

services and program activities with 

other similar programs. 

11. Establish (if not existing) a broadbased council with representative 

regional membership from the MCH 

community involved with AI/AN 

communities. These consortia will 

advise and support the program. Such 

an advisory council would consist of 

technical experts in MCH epidemiology; 

Title V (HRSA funded sites such as 

Healthy Starts), Fetal Infant Mortality 

Review teams, Perinatal Infant Mortality 

Review Teams, or Child Death Review 

Teams, perinatal clinical care networks 

and providers. These may include 

regional neonatal intensive care units, 

feto-maternal medicine units, State 

infant morality reduction initiatives, 

maternal tobacco or alcohol and drug 

exposure activities. Tribal and public 

health departments, community health 

representatives, public health nurse, 

health care providers, and others who 

could provide overall program direction 

and guidance should be involved. This 

consortium should be involved in 

recommendations for targeting of MCH 

public health needed by constituents. 

12. Provide annual, semiannual 

reports on activities to National MCH 

Epidemiology Project Manager. 

13. Provide letters of support for 

supplemental funding for the above 

outlined MCH activities by collaborating 

agencies, Tribal governments, etc. 

14. Include a line item budget, a 

budget justification and narrative for 

Program activities which must include 

planned travel to three national 

meetings/trainings as well as all local 

travel outlined in the workplan. 

Requirements of IHS Program Activities 

1. The IHS MCH Program will provide 

oversight and coordination of MCH 

activities at the Epicenters. A working 

relationship with Area and National 

Statistics Program will be maintained. 

2. Provide funded TEC with ongoing 

consultation and technical assistance in 

each of the above Recipient Activities 

components. 

3. Interpret current scientific 

literature related to epidemiology, 

statistics, surveillance, Healthy People 

2010 Objectives, and evidence-based 

practices. 

4. Assist in the implementation of 

each workplan component: needs 

assessment, surveillance, epidemiologic 

analysis, outbreak investigation, 

development of epidemiologic studies, 

development of disease control 

programs, and coordination of activities. 


rwilkins on PROD1PC63 with NOTICES
Federal Register / Vol. 72, No. 80 / Thursday, April 26, 2007 / Notices 20853 

5. Convene in conjunction with the 

annual CDC MCH Epidemiology 

meeting a workshop of funded 

organizations every year for 

information-sharing and problemsolving. 

6. Conduct site visits to assess 

program progress and mutually resolve 

problems, as needed, and/or coordinate 

reverse site visits. Provide linkages to 

other IHS programs on an as needed 

basis i.e. Injury Prevention, Emergency 

Medical Services for Children, 

Behavioral Health, and Statistics 

Program. 

7. Coordinate all MCH epidemiologic 

activities, reporting documents on a 

national basis. Review, make 

recommendations and approve 

semiannual and annual reports. 

Forward such reports to Agency and 

Closing the Health Disparities Gap 

Initiative leads. Disseminate findings 

and recommendations. 

8. Apprise National Programs in 

Albuquerque on updates on the Closing 

the Health Disparities GAP SIDS and 

Infant Mortality, and 

9. Oversee development, 

implementation and participate in the 

annual Epicenter MCH meetings and 

trainings. 

Eligibility Information 

1. Eligible Applicant: Urban Indian 

Organizations, as defined by 25 U.S.C. 

1603(h), Tribal Organizations, and 

federally recognized Tribes that 

currently operate IHS EpiCenters. 

IHS Epicenters serving AI/AN 

populations in Arizona, Iowa, Nebraska, 

Nevada, North Dakota, South Dakota, 

Utah, and/or with urban Indian 

organizations are eligible to submit 

proposals for this limited competition. 

Epicenters working in these states and 

metropolitan areas must require base 

funding to address IM in order to 

receive support. AI/AN Tribes, Tribal 

organizations, and eligible inter-Tribal 

consortia or Indian organizations 

representing a population of at least 

60,000 AI/AN will be considered to be 

eligible. A letter of support and 

collaboration should be included in the 

application. 

The following documentation is 

required to support the status of the 

organization: 

A. An official and signed Tribal 

Resolution(s). 

B. Nonprofit organizations must 

submit a copy of the 501 (c)(3) 

Certificate. 

2. Cost Sharing or Matching—The 

MCH Program does not require 

matching funds or cost sharing. 

3. Other Requirements—If the 

application budget exceeds $125,000 it 

will not be considered for review. 

Application and Submission 

Information 

1. Applicant package may be found in 

Grants.gov (www.grants.gov) or at: 

http://www.ihs.gov/ 

NonMedicalPrograms/gogp/ 

gogp_funding.asp. Information 

regarding the electronic application 

process may be directed to Michelle G. 

Bulls, at (301) 443–6290. 

2. Content and Form of Application 

Submission: 

• Be single spaced. 

• Be typewritten. 

• Have consecutively numbered 

pages. 

• Use black type not smaller than 12 

characters per one inch. 

• Contain a narrative that does not 

exceed 12 typed pages that includes the 

other submission requirements below. 

The 12 page narrative does not include 

the work plan, standard forms, Tribal 

resolutions or letters of support (if 

necessary), table of contents, budget, 

budget justifications, narratives, and/or 

other appendix items. 

Public Policy Requirements: All 

Federal-wide public policies apply to 

IHS grants with exception of Lobbying 

and Discrimination. 

3. Submission Dates and Times: 

Applications must be submitted 

electronically through Grants.gov by 12 

midnight Eastern Standard Time (EST). 

If technical challenges arise and the 

applicant is unable to successfully 

complete the electronic application 

process, the applicant must contact 

Michelle G. Bulls, Grants Policy Staff 

fifteen days prior to the application 

deadline and advise of the difficulties 

that your organization is experiencing. 

The grantee must obtain prior approval, 

in writing (e-mails are acceptable) 

allowing for paper submission. 

Otherwise, applications not submitted 

through Grants.gov will be returned to 

the applicant without review or 

consideration. The paper application 

(original and 1 copy) must be mailed to 

the Division of Grants Operations 

(DGO), 801 Thompson Avenue, TMP 

360, Rockville, MD 20852 by May 15, 

2007. Applicants should request a 

legibly dated U.S. Postal Service 

postmark or obtain a legibly dated 

receipt from a commercial carrier or 

U.S. Postal Service. Private metered 

postmarks will not be acceptable as 

proof of timely mailing. Late 

applications will not be considered for 

review and will be returned to the 

applicant without further consideration. 

4. Intergovernmental Review: 

Executive Order 12372 requiring 

intergovernmental review is not 

applicable to this program. 

5. Funding Restrictions: 

∑ Pre-award costs are allowable 

pending prior approval from the 

awarding agency. However, in 

accordance with 45 CFR part 74 all preaward costs are incurred at the 

recipient’s risk. The awarding office is 

under no obligation to reimburse such 

costs if for any reason the applicant 

does not receive an award or if the 

award to the recipient is less than 

anticipated. 

• The available funds are inclusive of 

direct and appropriate indirect costs. 

• Only one cooperative agreement 

will be awarded per applicant. 

• IHS will not acknowledge receipt of 

applications. 

6. Other Submission Requirements: 

Electronic Submission—The preferred 

method for receipt of applications is 

electronic submission through 

Grants.gov. However, should any 

technical challenges arise regarding the 

submission, please contact Grants.gov 

Customer Support at 1–800–518–4726 

or support@grants.gov. The Contact 

Center hours of operation are Monday—

Friday from 7 a.m. to 9 p.m. EST. If you 

require additional assistance please call 

(301) 443–6290 and identify the need 

for assistance regarding your Grants.gov 

application. Your call will be 

transferred to the appropriate grants 

staff member. The applicant must seek 

assistance at least fifteen days prior to 

the application deadline. Applicants 

that don’t adhere to the timelines for 

Central Contractor Registry (CCR) and/ 

or Grants.gov registration and/or 

requesting timely assistance with 

technical issues will not be a candidate 

for paper applications. 

To submit an application 

electronically, please use the http:// 

www.Grants.gov apply site. Download a 

copy of the application package, on the 

Grants.gov Web site, complete it offline 

and then upload and submit the 

application via the Grants.gov site. You 

may not e-mail an electronic copy of a 

grant application to IHS. 

Please be reminded of the following: 

• Under the new IHS application 

submission requirements, paper 

applications are not the preferred 

method. However, if you have technical 

problems submitting your application 

on-line, please directly contact 

Grants.gov Customer Support at: http:// 

www.grants.gov/CustomerSupport 

• Upon contacting Grants.gov obtain 

a tracking number as proof of contact. 

The tracking number is helpful if there 

are technical issues that cannot be 


rwilkins on PROD1PC63 with NOTICES
20854 Federal Register / Vol. 72, No. 80 / Thursday, April 26, 2007 / Notices 

resolved and a waiver request from 

Grants Policy must be obtained. 

• If it is determined that a formal 

waiver is necessary, the applicant must 

submit a request, in writing (e-mails are 

acceptable), to Michelle.Bulls@ihs.gov 

that includes a justification for the need 

to deviate from the standard electronic 

submission process. Upon receipt of 

approval, a hard-copy application 

package must be downloaded by the 

applicant from Grants.gov, and sent 

directly to the Division of Grants 

Operations, 801 Thompson Avenue, 

TMP 360, and Rockville, MD 20852 by 

the due date, May 15, 2007. 

• Upon entering the Grants.gov site, 

there is information available that 

outlines the requirements to the 

applicant regarding electronic 

submission of an application through 

Grants.gov, as well as the hours of 

operation. We strongly encourage all 

applicants not to wait until the deadline 

date to begin the application process 

through Grants.gov as the registration 

process for CCR and Grants.gov could 

take up to fifteen working days. 

• To use Grants.gov, you, as the 

applicant, must have a DUNS Number 

and register in the CCR. You should 

allow a minimum of ten days working 

days to complete CCR registration. See 

below on how to apply. 

• You must submit all documents 

electronically, including all information 

typically included on the SF–424 and 

all necessary assurances and 

certifications. 

• Please use the optional attachment 

feature in Grants.gov to attached 

additional documentation that may be 

requested by IHS. 

• If Tribal resolutions or letters of 

support are required, please fax it to the 

Grants Management Specialist 

identified in this announcement. 

• Your application must comply with 

any page limitation requirements 

described in the program 

announcement. 

• After you electronically submit 

your application, you will receive an 

automatic acknowledgment from 

Grants.gov that contains a Grants.gov 

tracking number. The IHS, DGO will 

retrieve your 13 application from 

Grants.gov. DGO will not notify 

applicants that the application has been 

received. 

• You may access the electronic 

application for this program on http:// 

www.Grants.gov. 

• You must search for the 

downloadable application package 

CFDA number 93.231. 

E-mail applications will not be 

accepted under this announcement. 

DUNS Number 

Applicants are required to have a Dun 

and Bradstreet (DUNS) number to apply 

for a grant or cooperative agreement 

from the Federal Government. The 

DUNS number is a nine-digit 

identification number, which uniquely 

identifies business entities. Obtaining a 

DUNS number is easy and there is no 

charge. To obtain a DUNS number, 

access http:// 

www.dunandbradstreet.com or call 1–

866–705–5711. Interested parties may 

wish to obtain their DUNS number by 

phone to expedite the process. 

Applications submitted electronically 

must also be registered with the CCR. A 

DUNS number is required before CCR 

registration can be completed. Many 

organizations may already have a DUNS 

number. Please use the number listed 

above to investigate whether or not your 

organization has a DUNS number. 

Registration with the CCR is free of 

charge. 

Applicants may register by calling 1–

888–227–2423. Please review and 

complete the CCR Registration 

Worksheet located on http:// 

www.grants.gov/CCRRegister. 

More detailed information regarding 

these registration processes can be 

found at http://www.grants.gov. 

Application Review Information 

The MCH Program has as its goal the 

reduction of IM and its underlying 

causes to a rate of 4.5 infant deaths per 

1,000 live births by the year 2010. 

1. Criteria 

A. Introduction, Current Capacity, and 

Need for Assistance (20 Points) 

1. Describe the applicant’s current 

MCH epidemiology activities including 

whether the applicant has an adequate 

health department, how long it has been 

operating, what MCH programs or MCH 

surveillance is currently provided that 

would be augmented, and interactions 

with other MCH public health 

authorities in the regions (State, local, or 

Tribal). 

2. Provide a physical location of the 

TEC and area to be served by the 

proposed project including a map 

(include the map in the attachments). 

3. Describe the relationship between 

this program and other funded work 

relevant to MCH that is planned, 

anticipated, or underway. 

Project Work Plan and Objectives (40 

Points) 

1. State in measurable and realistic 

terms the objectives and appropriate 

activities to achieve the program goals 

as listed below. 

a. Enhance surveillance of perinatal 

disease conditions. 

b. Conduct epidemiologic analysis, 

interpretation, and dissemination of 

surveillance data. 

c. Investigate outbreaks or elevated 

rates. 

d. Develop and implement 

epidemiologic studies where 

appropriate. 

e. Develop and implement SIDS 

reduction and risk reduction programs 

and coordination of activities with other 

public health authorities in the region. 

2. Identify the expected results, 

benefits, and outcomes or products to be 

derived from each objective ofthe 

project. 

3. Include a work plan for each 

objective that indicates when the 

objectives and major activities will be 

accomplished and who will conduct the 

activities on a calendar time line. 

4. Specify the responsible person who 

will review and accept the work to be 

performed. 

C. Project Evaluation (15 Points) 

1. State how project objectives will be 

achieved. 

2. Define the criteria to be used to 

evaluate results. 

3. Explain the methodology that will 

be used to determine if the needs 

identified for the project are being met 

and if the outcomes identified are being 

achieved. 

Organization Capabilities and 

Qualifications (15 Points) 

1. Explain the management and 

administrative structure of the 

organization including documentation 

of current certified financial 

management systems from the Bureau of 

Indian Affairs, IHS, or a Certified Public 

Accountant and an updated 

organization chart (include chart in the 

attachments). 

2. Describe the ability of the 

organization to manage a project of the 

proposed scope. 

3. Provide position descriptions and 

resumes/biosketch of key personnel, 

including those of consultants or 

contractors in the Appendix. Position 

descriptions should very clearly 

describe each position and its duties, 

indicating desired qualification and 

experience requirements related to the 

project. Resumes should indicate that 

the proposed staff is qualified to carry 

out the project activities. 

E. Categorical Budget and Budget 

Justification (10 Points) 

1. Provide a detailed budget by line 

item for each year. 

2. Provide a justification by line item 

in the budget including sufficient cost 


rwilkins on PROD1PC63 with NOTICES
Federal Register / Vol. 72, No. 80 / Thursday, April 26, 2007 / Notices 20855 

and other details to facilitate the 

determination of cost allowability and 

relevance of these costs to the proposed 

project. The funds requested should be 

appropriate and necessary for the scope 

of the project. 

3. Describe where the TEC will be 

housed, i.e., facilities and equipment 

available. 

4. Provide a detailed scope of work 

that clearly defines the deliverables or 

outcomes for a consultant or contractor, 

if applicable. 

5. If applicant is requesting indirect 

cost rate (IDC), a current negotiated rate 

must be submitted as an attachment 

with the application. 

6. Attachments to include: 

a. Attached resumes/bio-sketch and 

job descriptions for the key staff. 

b. Current approved organizational 

chart. 

c. A map of the area to benefit from 

the project. 

d. Copy of the negotiated IDC rate 

agreement, if applicable. 

e. Letters of support/collaboration. 

2. Review and Selection Process 

Applications submitted by the closing 

date and verified by electronic 

submission or the postmark under this 

program announcement will undergo a 

review to determine that: 

A. The applicant is eligible in 

accordance with the Eligibility Section 

of this application. 

B. Letters of support/collaboration are 

included. 

C. The application executive 

summary, forms and materials 

submitted are adequate to allow the 

review panel to undertake an in-depth 

evaluation. 

D. The application complies with this 

announcement; otherwise it will be 

returned without consideration. 

3. Competitive Review of Eligible 

Application Review 

May 17, 2007. 

Applications meeting eligibility 

requirements that are complete, 

responsive, and conform to this program 

announcement will be reviewed for 

merit by assigned field readers 

appointed by the IHS to review and 

make recommendations on these 

applications. The reviews will be 

conducted in accordance with the IHS 

objectives review procedures. The 

technical review process ensures 

selection of quality projects in a 

national competition for limited 

funding. Applications will be evaluated 

and rated on the basis of the list above. 

VI. Award Administration Information 

1. Award Notices 

The Notice of Award (NoA) will be 

initiated by the DGO and will be mailed 

via postal mail to each entity that is 

approved for funding under this 

announcement. The NoA will be signed 

by the Grants Management Officer and 

this is the authorizing document for 

which funds are dispersed to the 

approved entities. The NoA will serve 

as the official notification of the grant 

award and will reflect the amount of 

Federal funds awarded the purpose of 

the grant, the terms and conditions of 

the award, the effective date of the 

award, and the budget/project period. 

The NoA is the legal binding document. 

Applicants who are approved but 

unfunded or disapproved based on their 

Objective Review score will receive a 

copy of the Executive Summary which 

identifies the weaknesses and strengths 

of the application submitted. 

2. Administrative and National Policy 

Requirements 

Grants are administrated in 

accordance with the following 

documents: 

• This Program Announcement. 

• 45 CFR part 92, ‘‘Uniform 

Administrative Requirements for Grants 

and Cooperative Agreements to State, 

Local and Tribal Governments,’’ or 45 

CFR part 74, ‘‘Uniform Administrative 

Requirements for Awards to Institutions 

of Higher Education, Hospitals, Other 

Non-Profit Organizations, and 

Commercial Organizations, (Title 2 part 

230). 

• Grants Policy Guidance: HHS 

Grants Policy Statement, January 2007. 

• Appropriate Cost Principles: OMB 

Circular A–87, ‘‘State, Local, and Indian 

Tribal Governments,’’ or OMB Circular 

A–122, ‘‘Non-profit Organizations.’’

• OMB Circular A–133, ‘‘Audits of 

States, Local Governments, and Nonprofit Organizations.’’

• Other applicable OMB circulars. 

• Indirect Costs: This section applies 

to all grant recipients that request IDC 

in their application. In accordance with 

HHS Grants Policy Statement, Part II–

27, IHS requires applicants to have a 

current IDC rate agreement in place 

prior to award. The rate agreement must 

be prepared in accordance with the 

applicable cost principles and guidance 

as provided by the agency or office. A 

current rate means the rate covering the 

applicable activities and the award 

budget period. If the current rate is not 

on file with the awarding office, the 

indirect cost portion will be restricted 

until the current rate is provided to 

DGO. 

Generally, IDC rates for IHS Tribal 

organization grantees are negotiated 

with the Division of Cost Allocation 

http://rates.psc.gov/ and IDC rates for 

Federal recognized Tribes are 

negotiation with the Department of 

Interior. If your organization has 

questions regarding the IDC policy, 

please contact the DGO at 301–443–

5204. 

3. Reporting 

A. Progress Report. Progress reports 

are required semi-annually. These 

reports will include a brief comparison 

of actual accomplishments to the goals 

and tasks established for the period, 

reasons for slippage (if applicable), and 

other pertinent information as required. 

A final report must be submitted within 

90 days of expiration of the budget/ 

project period. 

B. Financial Status Report. Semiannual financial status report must be 

submitted within 30 days of the end of 

the six month period. Final financial 

status report is due within 90 days after 

the expiration of the budget/project 

period. Standard Form 269 (long form) 

must be used for financial reporting 

report unless the grantee generates 

Program Income, and then the Standard 

From 269 (short form) must be used. 

Grantees are responsible and 

accountable for accurate reporting of the 

Progress Report and Financial Status 

Report which are generally due semiannually. Financial Status Report (SF–

269) is due 90 days after each budget 

period and the final SF–269 must be 

verified from the grantee records on 

how the value was derived. Grantees 

must submit reports in a reasonable 

period of time. 

Failure to submit required reports 

within the time allowed may result in 

suspension or termination of an active 

grant, withholding of additional awards 

for the project, or other enforcement 

actions such as withholding of 

payments or converting to the 

reimbursement method of payment. 

Continued failure to submit required 

reports may result in one or both of the 

following: (1) The imposition of special 

award provisions; and (2) the nonfunding or non-award of other eligible 

projects or activities. This applies 

whether the delinquency is attributable 

to the failure of the grantee organization 

or the individual responsible for 

preparation of the reports. 

Telecommunication for the hearing 

impaired is available at: TTY 301–443–

6394. 

VII. Agency Contact(s) 

1. For program-related information: 

Judith Thierry, D.O., M.P.H., Maternal 


rwilkins on PROD1PC63 with NOTICES
20856 Federal Register / Vol. 72, No. 80 / Thursday, April 26, 2007 / Notices 

and Child Health Coordinator, Maternal 

and Child Health Program, Indian 

Health Service, 801 Thompson Avenue, 

Suite 300, Rm 313, Rockville, Maryland 

20852, voice: 301–443–5070, fax: 301–

594–6213 or judith.thierry@ihs.gov. 

For general information regarding this 

announcement: Ms. Orie Platero, IHS 

Headquarters, Office of Clinical and 

Preventive Services, 801 Thompson 

Avenue, Room 326, Rockville, MD 

20852, (301) 443–2522 or 

orie.platero@ihs.gov. 

3. For specific grant-related and 

business management information: 

Martha Redhouse, Grants Management 

Specialist, 801 Thompson Avenue, TMP 

360, Rockville, MD 20852, 301–443–

5204 or Martha.redhouse@ihs.gov. 

VIII. Other Information 

The IHS is focusing efforts on three 

health initiatives that linked together, 

have the potential to achieve positive 

improvements in the health of American 

Indian and Alaska Native (AI/AN) 

people. These three initiatives are 

Health Promotion/Disease Prevention, 

Management of Chronic Disease, and 

Behavioral Health. Further information 

is available at the Health Initiatives Web 

site: http://www.ihs.gov/nonMedical/ 

Programs/DirInitiatives/index.cfm. 

This agreement supports the 

Department of Health and Human 

Services’ objective in FY 2006 to 

transform the health care system as well 

as the FY 2007 objective to emphasize 

prevention and healthy living as well as 

to accelerate personalized health care. 

Dated: April 19, 2007. 

Robert G. McSwain, 

Deputy Director, Indian Health Service. 

[FR Doc. 07–2051 Filed 4–25–07; 8:45 am] 

BILLING CODE 4165–16–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Government-Owned Inventions; 

Availability for Licensing 

AGENCY: National Institutes of Health, 

Public Health Service, HHS. 

ACTION: Notice. 

SUMMARY: The inventions listed below 

are owned by an agency of the U.S. 

Government and are available for 

licensing in the U.S. in accordance with 

35 U.S.C. 207 to achieve expeditious 

commercialization of results of 

federally-funded research and 

development. Foreign patent 

applications are filed on selected 

inventions to extend market coverage 

for companies and may also be available 

for licensing. 

ADDRESSES: Licensing information and 

copies of the U.S. patent applications 

listed below may be obtained by writing 

to the indicated licensing contact at the 

Office of Technology Transfer, National 

Institutes of Health, 6011 Executive 

Boulevard, Suite 325, Rockville, 

Maryland 20852–3804; telephone: 301/ 

496–7057; fax: 301/402–0220. A signed 

Confidential Disclosure Agreement will 

be required to receive copies of the 

patent applications. 

Apparatus for Brachytherapy 

Description of Technology: Available 

for licensing and commercial 

development is a device for delivering 

targeted radiation brachytherapy to a 

portion of tissue in the cavity of a 

patient. The device includes an 

applicator with a balloon where in a 

deflated state is inserted into the body 

cavity and in an inflated state enlarges 

to fill the body cavity. The balloon 

moves from the deflated state into the 

inflated state upon introduction of 

pressurized fluid to the interior of the 

balloon. The apparatus also includes a 

catheter extending over at least a 

portion of the balloon for delivering 

treatment to the adjacent cavity (e.g., 

radiation or heat). A tracking device 

(e.g., a camera) is included in the 

apparatus for helping track the 

positioning of the balloon within the 

body cavity prior to inflation. The 

apparatus can be alternatively 

configured with a second balloon 

containing a therapeutic agent which is 

inflated after positioning and expansion 

with a first balloon first. 

Applications: Brachytherapy; 

Radiation dosing; Cancer therapy. 

Development Status: Early-stage; Preclinical data available; Prototype. 

Inventor: Anurag K. Singh (NCI). 

Patent Status: U.S. Provisional 

Application No. 60/811,762 filed 08 Jun 

2006 (HHS Reference No. E–314–2005/ 

0–US–01). 

Licensing Status: Available for 

licensing non-exclusively or exclusively 

to qualified applicants that satisfy the 

criteria set forth in 37 CFR 404.7. 

Licensing Contact: Michael A. 

Shmilovich, Esq.; 301/435–5019; 

shmilovm@mail.nih.gov. 

Dated: April 18, 2007. 

Steven M. Ferguson, 

Director, Division of Technology Development 

and Transfer, Office of Technology Transfer, 

National Institutes of Health. 

[FR Doc. E7–7927 Filed 4–25–07; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Government-Owned Inventions; 

Availability for Licensing 

AGENCY: National Institutes of Health, 

Public Health Service, HHS. 

ACTION: Notice. 

SUMMARY: The inventions listed below 

are owned by an agency of the U.S. 

Government and are available for 

licensing in the U.S. in accordance with 

35 U.S.C. 207 to achieve expeditious 

commercialization of results of 

federally-funded research and 

development. Foreign patent 

applications are filed on selected 

inventions to extend market coverage 

for companies and may also be available 

for licensing. 

ADDRESSES: Licensing information and 

copies of the U.S. patent applications 

listed below may be obtained by writing 

to the indicated licensing contact at the 

Office of Technology Transfer, National 

Institutes of Health, 6011 Executive 

Boulevard, Suite 325, Rockville, 

Maryland 20852–3804; telephone: 301/ 

496–7057; fax: 301/402–0220. A signed 

Confidential Disclosure Agreement will 

be required to receive copies of the 

patent applications. 

Biotinylated Alkylating Acridine for 

Pull-downs of Viral Pre-integration 

Complexes (PIC) or Other Cytosol 

Localized DNAs 

Description of Technology: The 

invention describes a DNA-binding 

molecule that allows recovery of viral 

DNA and associated proteins. An 

acridine orange based molecule was 

modified and the resulting alkylating 

acridine molecule intercalates with viral 

pre-integration complexes (PIC) or other 

DNAs localized in cytosol. Because the 

molecule is also biotinylated, 

streptavidin beads can be used to purify 

the molecule and the bound DNA and 

associated protein can subsequently be 

eluted and analyzed. The invention 

provides a useful tool to facilitate the 

studies for viral PIC and other cytosol 

DNAs. 

Applications: Research Tool. 

Development Status: In vitro data 

available. 

Inventors: Gunnar Thor Gunnarsson 

and Rafal Wierzchoslawski (NCI). 

Patent Status: HHS Reference No. E–

131–2007/0—Research Tool. 

Licensing Status: Available for nonexclusive licensing as biological 

material and research tool. 

Licensing Contact: Sally Hu, Ph.D.; 

301/435–5606; HuS@mail.nih.gov. 


rwilkins on PROD1PC63 with NOTICES